Peptides and engineered t cell receptors targeting mage-a4 antigen and methods …

Abstract

This disclosure provides for engineered T cell Receptors (TCRs), cells comprising the TCRs, and methods of making and using the TCRs. The current disclosure relates to TCRs that specifically recognize epitope(s) from tumor antigen MAGE-A4. Accordingly, aspects of the disclosure relate to an …